113 related articles for article (PubMed ID: 26816611)
1. Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Tajitsu M; Yamada T; Cao X; Fukui A; Nagai J; Yambe Y; Murase T; Okada H
J Diabetes Investig; 2016 Jan; 7(1):130-1. PubMed ID: 26816611
[TBL] [Abstract][Full Text] [Related]
2. A rare case of autoimmune polyglandular syndrome type 3.
Shimomura H; Nakase Y; Furuta H; Nishi M; Nakao T; Hanabusa T; Sasaki H; Okamoto K; Furukawa F; Nanjo K
Diabetes Res Clin Pract; 2003 Aug; 61(2):103-8. PubMed ID: 12951278
[TBL] [Abstract][Full Text] [Related]
3. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.
Dereke J; Nilsson C; Landin-Olsson M; Hillman M
Diabet Med; 2012 Dec; 29(12):e436-9. PubMed ID: 22924602
[TBL] [Abstract][Full Text] [Related]
5. Acute ataxia, Graves' disease, and stiff person syndrome.
Chia SY; Chua R; Lo YL; Wong MC; Chan LL; Tan EK
Mov Disord; 2007 Oct; 22(13):1969-71. PubMed ID: 17712846
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune chronic urticaria associated with type 1 diabetes and Graves' disease.
Asero R; Orsatti A; Tedeschi A; Lorini M
J Allergy Clin Immunol; 2005 May; 115(5):1088-9. PubMed ID: 15867871
[No Abstract] [Full Text] [Related]
7. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
Silva RC; Sallorenzo C; Kater CE; Dib SA; Falorni A
Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
[TBL] [Abstract][Full Text] [Related]
8. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
Kimura T; Okamoto Y
Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
[TBL] [Abstract][Full Text] [Related]
9. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
[TBL] [Abstract][Full Text] [Related]
10. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
11. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
12. Isolated extrapontine myelinolysis of osmotic demyelination syndrome.
Yilmaz O; Armagn HH; Turan A; Duymuş M
Prague Med Rep; 2013; 114(1):35-8. PubMed ID: 23547724
[TBL] [Abstract][Full Text] [Related]
13. [Graves' disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases].
Cohen Aubart F; Jublanc C; Bruckert E
Ann Endocrinol (Paris); 2007 Feb; 68(1):55-7. PubMed ID: 17292844
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
Sunwoo JS; Chu K; Byun JI; Moon J; Lim JA; Kim TJ; Lee ST; Jung KH; Park KI; Jeon D; Jung KY; Kim M; Lee SK
J Neuroimmunol; 2016 Jan; 290():15-21. PubMed ID: 26711563
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
Wilmot-Roussel H; Lévy DJ; Carette C; Caillat-Zucman S; Boitard C; Timsit J; Dubois-Laforgue D
Diabetes Metab; 2013 May; 39(3):244-9. PubMed ID: 23522731
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange as treatment for osmotic demyelination syndrome: Case report and review of current literature.
Nelson NR; Tompkins MG; Thompson Bastin ML
Transfus Apher Sci; 2019 Dec; 58(6):102663. PubMed ID: 31759898
[TBL] [Abstract][Full Text] [Related]
17. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
Hiromatsu Y; Mukai T; Kaku H; Miyake I; Ichimura M; Fukutani T; Nakayama H; Takata K; Imamura Y; Shoji S; Yamada K; Koda Y; Bednarczuk T
Diabet Med; 2006 Feb; 23(2):211-5. PubMed ID: 16433722
[TBL] [Abstract][Full Text] [Related]
18. [Antibodies to glutamic acid decarboxylase in patients with Graves disease].
An Z; Zhao H; Li S; Zhao G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):98-9. PubMed ID: 15600194
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
